{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:58:05Z","timestamp":1791979085511,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["114-SS0012"],"award-info":[{"award-number":["114-SS0012"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2314-B-002-126-MY3"],"award-info":[{"award-number":["113-2314-B-002-126-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW113-TDU-B-211-114006"],"award-info":[{"award-number":["MOHW113-TDU-B-211-114006"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jmii.2025.09.001","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T15:17:21Z","timestamp":1756826241000},"page":"364-371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Linezolid versus daptomycin for VRE bloodstream infections in patients with malignancy: The impact of neutropenia on outcomes"],"prefix":"10.1016","volume":"59","author":[{"given":"Ming-Tao","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chung","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hsi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann-Tay","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1816-9010","authenticated-orcid":false,"given":"Yee-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2025.09.001_bib1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13756-018-0353-x","article-title":"Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany - 10 years of surveillance","volume":"7","author":"Remschmidt","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jmii.2025.09.001_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlab185","article-title":"Replacement of Enterococcus faecalis by Enterococcus faecium as the predominant enterococcus in UK bacteraemias","volume":"3","author":"Horner","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.jmii.2025.09.001_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2020.106463","article-title":"Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia","volume":"99","author":"Kirkizlar","year":"2020","journal-title":"Leuk Res"},{"key":"10.1016\/j.jmii.2025.09.001_bib4","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/cid\/ciz031","article-title":"Bloodstream infection due to vancomycin-resistant enterococcus is associated with increased mortality after hematopoietic cell transplantation for acute leukemia and myelodysplastic syndrome: a multicenter, retrospective cohort study","volume":"69","author":"Papanicolaou","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.09.001_bib5","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1128\/AAC.02943-14","article-title":"Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci","volume":"58","author":"Hayakawa","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2025.09.001_bib6","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.01289-13","article-title":"Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia","volume":"58","author":"Balli","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2025.09.001_bib7","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/cid\/ciw815","article-title":"Comparative effectiveness and safety of Standard-, Medium-, and high-dose daptomycin strategies for the treatment of vancomycin-resistant enterococcal bacteremia among veterans affairs patients","volume":"64","author":"Britt","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.09.001_bib8","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/cid\/civ444","article-title":"Comparison of the effectiveness and safety of linezolid and daptomycin in vancomycin-resistant enterococcal bloodstream infection: a national cohort study of veterans affairs patients","volume":"61","author":"Britt","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.09.001_bib9","doi-asserted-by":"crossref","first-page":"890 e1","DOI":"10.1016\/j.cmi.2016.07.018","article-title":"Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose","volume":"22","author":"Chuang","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jmii.2025.09.001_bib10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1086\/383472","article-title":"Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens","volume":"38","author":"Carpenter","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.09.001_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab616","article-title":"Contemporary clinical and molecular epidemiology of vancomycin-resistant enterococcal bacteremia: a prospective multicenter cohort study (VENOUS I)","volume":"9","author":"Contreras","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jmii.2025.09.001_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkae380","article-title":"Bactericidal versus bacteriostatic antibacterials: clinical significance, differences and synergistic potential in clinical practice","volume":"80","author":"Ishak","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2025.09.001_bib13","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/jac\/dkac164","article-title":"Influence of daptomycin doses on the outcomes of VRE bloodstream infection treated with high-dose daptomycin","volume":"77","author":"Chuang","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2025.09.001_bib14","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/cid\/cir138","article-title":"Summary of recommendations: guidelines for the prevention of intravascular catheter-related infections","volume":"52","author":"O'Grady","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.09.001_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chron Dis"},{"key":"10.1016\/j.jmii.2025.09.001_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","article-title":"Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary","volume":"11","author":"Chow","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2025.09.001_bib17","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/cid\/cix024","article-title":"Effect of daptomycin dose on the outcome of Vancomycin-Resistant, Daptomycin-susceptible Enterococcus faecium bacteremia","volume":"64","author":"Chuang","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.09.001_bib18","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jinf.2006.11.007","article-title":"Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients","volume":"54","author":"Poutsiaka","year":"2007","journal-title":"J Infect"},{"key":"10.1016\/j.jmii.2025.09.001_bib19","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1128\/AAC.00943-08","article-title":"Daptomycin pharmacokinetics in adult oncology patients with neutropenic fever","volume":"53","author":"Bubalo","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2025.09.001_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113710","article-title":"Daptomycin area under the curve to minimum inhibitory concentration ratio by broth microdilution for predicting the outcome of vancomycin-resistant enterococcus bloodstream infection","volume":"155","author":"Chuang","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jmii.2025.09.001_bib21","first-page":"7","article-title":"Daptomycin use in neutropenic patients with documented gram-positive infections","volume":"22","author":"Rolston","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jmii.2025.09.001_bib22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s12325-015-0231-3","article-title":"Daptomycin for gram-positive infections in patients with neutropenia: clinical experience from a European outcomes registry","volume":"32","author":"Keil","year":"2015","journal-title":"Adv Ther"},{"key":"10.1016\/j.jmii.2025.09.001_bib23","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/j.clinthera.2016.09.011","article-title":"Vancomycin-resistant enterococcal bloodstream infections in hematopoietic stem cell transplant recipients and patients with hematologic malignancies: impact of daptomycin MICs of 3 to 4 mg\/L","volume":"38","author":"Chong","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.jmii.2025.09.001_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jinf.2014.05.018","article-title":"Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours","volume":"69","author":"Marin","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.jmii.2025.09.001_bib25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3343\/alm.2018.38.3.226","article-title":"Comparison of Enterococcus faecium bacteremic isolates from hematologic and non-hematologic patients: differences in antimicrobial resistance and molecular characteristics","volume":"38","author":"Cho","year":"2018","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.jmii.2025.09.001_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0053-2018","article-title":"Pathogenicity of enterococci","volume":"7","author":"Fiore","year":"2019","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jmii.2025.09.001_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1128\/IAI.00863-08","article-title":"Neutrophils are essential for rapid clearance of Enterococcus faecium in mice","volume":"77","author":"Leendertse","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.jmii.2025.09.001_bib28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s13054-018-2076-z","article-title":"Influence of neutropenia on mortality of critically ill cancer patients: results of a meta-analysis on individual data","volume":"22","author":"Georges","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.jmii.2025.09.001_bib29","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1086\/381972","article-title":"Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections","volume":"38","author":"Pankey","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.09.001_bib30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1086\/500139","article-title":"Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer","volume":"42","author":"Jaksic","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.09.001_bib31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1586\/eri.09.11","article-title":"Linezolid for patients with neutropenia: are bacteriostatic agents appropriate?","volume":"7","author":"Rafailidis","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jmii.2025.09.001_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13631","article-title":"Secular trends of blood stream infections in allogeneic hematopoietic cell transplant recipients 72 hours prior to death","volume":"23","author":"Mani","year":"2021","journal-title":"Transpl Infect Dis"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118225001872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118225001872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T07:28:54Z","timestamp":1779866934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118225001872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1684118225001872"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2025.09.001","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linezolid versus daptomycin for VRE bloodstream infections in patients with malignancy: The impact of neutropenia on outcomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2025.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}